CYTIMMUNE-EU LIMITED
CANNON PLACE, 78 CANNON STREET, LONDON  EC4N 6AF- Active
- Private Limited Company
- Company No. 06623701
- Last Updated: 01 Oct 2022
Company Profile
CYTIMMUNE-EU LIMITED was incorporated on Wednesday, June 18, 2008 as a Private Limited Company with registered address in LONDON. CYTIMMUNE-EU LIMITED has the status: Active and it's listed in the following category: Non-trading company. This Private Limited Company has been operating for 16 years 4 months and 20 days.
Name | CYTIMMUNE-EU LIMITED |
---|---|
Company number | 06623701 |
Company type | Private Limited Company |
Incorporation date | 18 Jun 2008 |
Status | Active |
Industry (SIC 2007) |
Address
Registered Address |
CANNON PLACE 78 CANNON STREET LONDON EC4N 6AF |
---|---|
Country Of Origin | ENGLAND |
Map based on PostCode
Ownership Information
Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.
Name | Nature of Control |
---|---|
Mr Lawrence Tamarkin Nationality: American |
Dates: Tuesday, March 6, 2018 - present
ownership of shares 75 to 100 percent
voting rights 75 to 100 percent
right to appoint and remove directors
|
Mr Kentaro Hidetaka Itani Nationality: American |
Dates: Tuesday, March 6, 2018 - present
ownership of shares 75 to 100 percent
voting rights 75 to 100 percent
right to appoint and remove directors
|
Cytimmune Sciences, Inc Broschart Road, Suite 270, 20850 |
Dates: Tuesday, March 6, 2018 - present
ownership of shares 75 to 100 percent
voting rights 75 to 100 percent
right to appoint and remove directors
|
Accounts and Confirmation
Type of accounts | DORMANT |
---|---|
End of financial Year | 31 December |
Next annual accounts due | 30 September 2022, (-770 days left) |
Latest accounts | 31 December 2020 |
Next confirmation statement due | 16 July 2017 |
Last confirmation statement dated | 18 June 2016 |
Mortgages
No mortgages have been registered against CYTIMMUNE-EU LIMITED.
Previous Names
Name | Change Date |
---|---|
CYTIMMUNE-EU LIMITED | 18 Jun 2008 |
CYTLMMUNE-EU LIMITED | 02 Sep 2008 |